Skip to main content
. 2024 Sep 3;10:79. doi: 10.1038/s41522-024-00558-w

Fig. 11. Mouse primary splenic NK cells were collected from wild-type mice and co-cultured with bacteria for 3 h.

Fig. 11

A Percent viable K. pneumoniae (ATCC 43816), K. pneumoniae (clinical isolate 1), and K. pneumoniae (clinical isolate 2). Primary control NK cells were pre-treated with various inhibitors prior to co-culturing with K. pneumoniae or S. pneumoniae. Percent viable (B) K. pneumoniae and (C) S. pneumoniae 3 h. post co-culture with inhibitor pre-treatment. N = 6–10 wells of primary NK cells derived from 2 independent experiments. N = 3 wells of primary NK cells for the combo treatment with CMA and Granzyme B IV inhibitors derived from 1 experiment.